{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 3,
        "end": 9
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 32,
        "end": 38
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 325,
        "end": 331
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 363,
        "end": 369
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 406,
        "end": 416
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "18429967_8",
  "text": "In CYP3A5 * 1 allele carriers ( CYP3A5 expressers ) , body weight-adjusted oral clearance was markedly decreased from the early stage to the maintenance stage [ 0.622 ( 0.534 , 0.709 ) to 0.369 l h ( -1 ) kg ( -1 ) ( 0.314 , 0425 ) ] compared with a smaller decrease [ 0.368 ( 0.305 , 0.430 ) to 0.305 ( 0.217 , 0.393 ) ] in CYP3A5 non-expressers ; however , the CYP3A5 genetic variation did not influence tacrolimus chronopharmacokinetics ."
}
